Rota Paul A, Evans Roger, Ben Mamou Myriam Corinne, Rey-Benito Gloria, Sangal Lucky, Dosseh Annick, Ghoniem Amany, Byabamazima Charles R, Demanou Maurice, Anderson Raydel, Kim Gimin, Bankamp Bettina, Beard R Suzanne, Crooke Stephen N, Ramachandran Sumathi, Penedos Ana, Stambos Vicki, Nicholson Suellen, Featherstone David, Mulders Mick N
Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
World Health Organization Western Pacific Regional Office, Manila 1000, Philippines.
Vaccines (Basel). 2024 Aug 22;12(8):946. doi: 10.3390/vaccines12080946.
With 762 laboratories, the Global Measles and Rubella Laboratory Network (GMRLN) is the largest laboratory network coordinated by the World Health Organization (WHO). Like the Global Polio Laboratory Network, the GMRLN has multiple tiers, including global specialized laboratories, regional reference laboratories, national laboratories, and, in some countries, subnational laboratories. Regional networks are supervised by regional laboratory coordinators reporting to a global coordinator at WHO headquarters. Laboratories in the GMRLN have strong links to national disease control and vaccination programs. The GMRLN's goal is to support member states in obtaining timely, complete, and reliable laboratory-based surveillance data for measles and rubella as part of the strategy for achieving measles and rubella elimination. Surveillance data are reported to the national program and are included in annual reports on the status of measles and rubella elimination to national verification committees for review by regional verification commissions. Quality within the GMRLN is ensured by monitoring performance through external quality assurance programs, confirmatory and quality control testing, accreditation, and coordination of corrective action and training where needed. The overall performance of the laboratories has remained high over the years despite many challenges, particularly the COVID-19 pandemic. The GMRLN is well-positioned to support high-quality laboratory-based surveillance for measles and rubella and to transition to supporting laboratory testing for other pathogens, including vaccine-preventable diseases.
全球麻疹和风疹实验室网络(GMRLN)拥有762个实验室,是世界卫生组织(WHO)协调的最大实验室网络。与全球脊髓灰质炎实验室网络一样,GMRLN也有多个层级,包括全球专业实验室、区域参考实验室、国家实验室,在一些国家还包括次国家级实验室。区域网络由区域实验室协调员监督,这些协调员向WHO总部的全球协调员汇报工作。GMRLN中的实验室与国家疾病控制和疫苗接种计划有着紧密联系。GMRLN的目标是支持成员国获取及时、完整且可靠的基于实验室的麻疹和风疹监测数据,作为实现消除麻疹和风疹战略的一部分。监测数据会上报给国家计划,并包含在向国家核查委员会提交的麻疹和风疹消除状况年度报告中,以供区域核查委员会审查。GMRLN内部的质量通过外部质量保证计划、确证和质量控制检测、认证以及在必要时协调纠正措施和培训来监测绩效得以确保。尽管面临诸多挑战,尤其是新冠疫情,但多年来这些实验室的整体表现一直很高。GMRLN处于有利地位,能够支持高质量的基于实验室的麻疹和风疹监测,并过渡到支持对包括疫苗可预防疾病在内的其他病原体进行实验室检测。